Actively Recruiting
Microvascular Monitoring in Circulatory Shock and Sepsis (MiMICSS)
Led by University of Manitoba · Updated on 2025-08-24
100
Participants Needed
1
Research Sites
209 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Investigation of the feasibility of using near-infrared spectroscopy (NIRS) to monitor microvascular function in critically ill patients.
CONDITIONS
Official Title
Microvascular Monitoring in Circulatory Shock and Sepsis (MiMICSS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Admitted to ICU
- Receiving invasive mechanical ventilation
You will not qualify if you...
- Body Mass Index >40
- More than 24 hours has elapsed since ICU admission
- Death is deemed to be imminent and inevitable during the next 24 hours
- Known allergy to the textile components of the device
- Significant clinical jaundice, ecchymosis
- COVID positive microbiological result
- The treating clinician believes that participation in the domain would not be in the best interests of the patient
- Consent declined from patient or authorized third party
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Health Sciences Centre Winnipeg
Winnipeg, Manitoba, Canada, R3A 1R9
Actively Recruiting
Research Team
A
Asher Mendelson, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here